TABLE I

Chemical Structure of Characteristic Parts of Glycoconjugates and Saccharides Tested for Receptor Activity
GalB1--~tGlcB-O-Et GaiB1--~GIcNAca 1 -O-Me 
2-Acetamido-2-deoxy-4-O-([3-o-galactopyranosyl)-o-glucose (13):
Bacterial Binding Assays
Epithelial Cell Adherence. The binding to human nasopharyngeal epithelial cells was assayed in vitro as previously described (7) . Saline suspension of bacteria (109/ml) and pharyngeal epithelial cells from a healthy male donor (104/ml) were mixed to an end volume of 200 #1, centrifuged at 1,500 g for 10 min, and incubated at 37°C for 30 min. After washing twice in 2.5 ml of saline to separate epithelial cells from unattached bacteria the number of bacteria adhering to 40 epithelial cells were counted and the mean number per cell was determined.
Hemagglutination. Adhering bacteria may be expected to bind to any target cell or surface where receptors are present. Bacterial binding to erythrocytes, resulting in hemagglutination has been a useful tool to approach mechanisms of binding. Thus, the ability of the adhering pneumococci to agglutinate erythrocytes was investigated. Freshly drawn citrated blood was washed and 5% suspensions in saline of human, bovine, rabbit, and guinea pig erythrocytes were prepared. Human O, A, B, AB, and cord blood samples were provided by the blood bank of Sahlgren's Hospital, G6teborg, Sweden. For enzymatic treatment the 5% suspensions were mixed with Papain (Kebo Grave, Stockholm, Sweden) or neuraminidase (Sigma Chemical Co., St. Louis, MO) to a final concentration of 1 mg/ ml and rotated at 37°C for 30 min. After washing twice the suspension was readjusted to 5%. Bacterial and erythrocyte suspensions (25 t*l of each) were mixed on a microscope slide, and agglutination read by the naked eye.
Screening for Receptor Activity of the Glycoconjugates
Receptor activity of glycoconjugates or free oligosaccharides, was assayed in two main ways.
(a) Inhibition of binding by excess of the free sugar. The bacterial inoculum was preincubated with dilutions of the compounds with potential receptor activity, for 15 rain at 37°C. Subsequently epithelial cells were added and adhesion testing proceeded as described. The adhesion of the treated samples is given in per cent of the saline control. The variation between experiments is described by the range. The effective inhibitory oligosaccharide dose, EID75, required for 75% inhibition of adhesion is given.
(b) Induction of binding by coating with receptor. Association of receptor-active glycolipids with epithelial cells or erythrocytes might increase the bacterial binding to epithelial cells already containing the receptor or induce binding to cells previously lacking the receptor (12) . Rabbit erythrocytes (100 #1 of a 5% suspension) were mixed with neolactotetraosylceramide, sialylneolactotetraosylceramide, or globotetraosylceramide (500 #1 of suspensions of 200 tag/ml) and incubated at 37 ° for 3 h during rotation (12) . After elimination of unbound glycolipid by repeated washing, the erythrocyte concentration was readjusted to 5% and used for hemagglutination. In parallel with the adherence inhibition assays the human nasopharyngeal epithelial cells were pretreated with decreasing concentrations of glycolipid, incubated for 2 h at 37°C, washed, and used for adherence testing.
Results
Initial Studies. The focus on the neolactoseries of glycolipids as receptor candidates resulted from work with other glycoconjugates. Human plasma fibro-nectin inhibited adhesion (42% of saline control at 100 #g/ml). Increased attachment was obtained after pretreatment of the epithelial cells with 1 mg/ml of fibronectin (Table II) . E. coli LPS of serotypes 04 and 083 completely inhibited adhesion at 1 mg/ml. Partial inhibition resulted after pretreatment with R3 LPS at 1 mg/ml; R~, R2, and R4 were not inhibitory. No decrease in pneumococcal viability after treatment with glycoconjugates was detected by viable counts on 10-fold saline dilutions.
Compounds with potential receptor activity were selected for testing because of structural similarity to the known oligosaccharide sequences of fibronectin and Ra LPS.
Glycolipids. The receptor activity of the glycolipids is shown in Table II .
Pretreatment of the pneumococci with neolactotetraosylceramide inhibited adhe- sion (59% of saline control at 200 ~g/ml). Sialylneolactotetraosylceramide had no effect (Table II) . Coating of pharyngeal epithelial cells with 200 t~g/ml of neolactotetraosylceramide increased adhesion (Table III) while sialylneolactotetraosylceramide or giobotetraosylceramide had no effect at the same concentration. The structures of these compounds are shown in Table I .
Oligosaccharides. Of the purified oligosaccharides tested, neolactotetraose and lactotetraose were the best inhibitors, with an EID7~ of 1.5 and 1.0 mg/ml (Table III) . The "octasaccharide" from human urine had no effect. Lactose was inactive. Subsequent studies were concentrated on defining the active site in the tetrasaccharide sequence. N-acetyl-lactoseamine and a-methyl-N-acetyl-lactoseamine were inactive. Even in high concentrations/3-methyl and /~-ethyl-Nacetyl-lactoseamine only partially reduced adhesion (EID75 > 10 mg/ml). GIcNAc/31--->3Gal/3-O-Me abolished adhesion at 10 mg/ml with an EID75 of 4.5 mg/ml. The disaccharide was, thus, three times less active than the tetrasaccharides on a weight basis. The carbohydrate pneumococcal receptor was thus proposed to reside in the trisaccharide unit Gal/31--*4GIcNAc/31---*3GalB-with GIcNAcI31--*3GaiI3 as the principal binding site.
To test the generality of binding to GalB1---~3GIcNAcI31--*3Gal/31 ;~Glc as a mechanism of pneumococcal adhesion, seven strains with different capsular types and high adhesive capacity were used. Adhesion of all the strains tested was inhibited after pretreatment of the bacteria with lactotetraose (Table VI) . No correlation between inhibition and the capsular type of the pneumococcal strain was observed.
Hemagglutination. The pneumococcal strains did not agglutinate any of the erythrocyte species tested. After papain or neuraminidase treatment guinea pig and to a smaller extent bovine erythrocytes became agglutinable (Table V) . After coating with neolactotetraosylceramide (200 #g/ml) the previously inactive rabbit erythrocytes became agglutinable. Sialylneolactotetraosylceramide and glo-botetraosyiceramide were inactive.
Discussion
This study demonstrates specific attachment of pneumococci to glycoconjugate receptors where the disaccharide GlcNAc~$1--.3Galfl-is shown to be the main binding site. The high degree of specificity of this binding is shown by the lack of activity of GlcNAc$1--~4Gal$-O-Me (Table III) . The importance of the ~-configuration of the N-acetylglucoseaminosyl group was demonstrated by the inhibitory activity of ~-methyl but not a-methyl-N-acetyl-lactoseamine.
The identification of the receptor was done experimentally in several steps using inhibition and induction of binding. In analogy with Streptococcus pyogenes, the pneumococci bound human plasma fibronectin. In contrast to S. pyogenes, the pneumococci bound at the collagen-binding region of fibronectin. 2 The partly characterized oligosaccharide sequence at that site contains the "octasaccharide" (see 7 in Table I ), that did not inhibit adhesion. This does not contain the active disaccharide and did not inhibit adhesion (Table III) . Accordingly, this part of the fibronectin structure probably is not the pneumococcal binding site. The fibronectin-binding may involve other adhesion receptor interactions.
Receptor activity of the neolactoseries of glycolipids was indicated by the inhibition of adhesion obtained after pretreatment of bacteria with neolactotetraosylceramide and the increased binding after coating of epithelial cells and erythrocytes. Receptor activity of the ~-O linkage per se was unlikely, since lactose-~-O-Me did not inhibit adhesion. Receptor activity of the ceramide portion was ruled out, since e.g. sialylneolactotetraosylceramide was inactive. The complete inhibition of pneumococcal adhesion obtained with neolactotetraose and lactotetraose suggested that the receptor was a common feature of these tetrasaccharides. Since lactose, lactoseamine, and the "octasaccharide" (which contains two terminal lactoseamine residues) are all inefficient as inhibitots, it was thought that the central disaccharide portion of lactoneotetraose should be the active receptor. Accordingly, this compound (15 in Table I ) was synthesized in the form of its B-methyl glycoside. Testing of the inhibitory activity supported this assumption.
The varying ability to agglutinate erythrocytes of different species has been useful for classifying bacterial adhesins (3.5). The GIcNAcjOl--~3Gal has been identified as part of the saccharide chains of many glycolipids and glycoproteins including long chains containing repeating units of (--~GlcNAc~I--~3GaI~--~) (36, 37) . It has been identified in human (36, 37) , ox (38, 39) , rabbit (40) , and sheep (41) erythrocytes, but so far not in guinea pig erythrocytes (42) . Thus a correlation between presence of receptor-active oligosaccharide and pneumococcal hemagglutination was not apparent (Table V) as found between hemagglutination by uropathogenic E. coli and the presence of the Galal--~Gal sequence (2) . The receptor activity may depend not only on the presence but also on availability of the receptor in the cell surface micro-environment (36) .
The identification of the interaction of pneumococci with specific saccharides is interesting from many biological and medical points of view. The disaccharide GIcNAc~Ol--~3GaI~-(substituted at various positions) is part of many saccharide chains active as blood group ABH, Lewis, or Ii antigens (37) . Its presence and availability therefore may be subject to variations between individuals, and may affect the susceptibility to pneumococcal infection. Compare the relation between P blood group phenotype and urinary tract infection (43) . Our preliminary results indicate that epithelial cells from patients with frequent attacks of otitis media have an increased receptivity for adhering pneumococci compared with cells from age matched controls (44) . The inhibitory effect of receptor oligosaccharides in vitro might be used to inhibit bacterial adhesion in vivo. The principal usefulness of this approach has been demonstrated in other infections (45, 46) . Furthermore pneumococcal adhesion was also inhibited by a fraction of human milk rich in oligosaccharides and from which antibodies had been removed. The natural presence of neolacto-and lactotetraose in human milk and colostrum (20) may interfere with pneumococcal colonization in the newborn, and could in part explain the suggested positive effect of breast feeding on otitis media (47, 48) .
Summary
Glycoconjugates containing the disaccharide unit GlcNAc/31--*3Gal/3 were suggested as receptors for pneumococci adhering to human pharyngeal epithelial cells. The receptor activity was detected both by inhibition of adhesion by an excess of free oligosaccharide and by induction or increase of adhesion after coating of target cells with glycolipid. Studies with free natural and synthetic oligosaccharides identified the disaccharide GicNAc/31--*3Gal/3 as one critical binding site. The specificity of recognition was shown inter alia by the lack of inhibitory activity of GIcNAcI31-->4GalB, which differs only in the linkage of the two sugars. Specific interference with pneumococcal adhesion by administration of soluble receptor sugar may improve our understanding of the role of adhesion in vivo.
